Anika Therapeutics, Inc. financial data

Symbol
ANIK on Nasdaq
Location
32 Wiggins Avenue, Bedford, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 546 % -1.06%
Quick Ratio 103 % -30.9%
Return On Equity -22.1 % +54%
Return On Assets -17.2 % +54.8%
Operating Margin -11 % -147%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14.4M shares -1.53%
Common Stock, Shares, Outstanding 14.4M shares -1.86%
Entity Public Float 373M USD +0.73%
Common Stock, Value, Issued 144K USD -2.04%
Weighted Average Number of Shares Outstanding, Basic 14.4M shares -2.36%
Weighted Average Number of Shares Outstanding, Diluted 14.4M shares -2.36%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 113M USD +30.6%
Research and Development Expense 25.8M USD +64.5%
Costs and Expenses 74.2M USD +67.2%
Operating Income (Loss) -12.4M USD -161%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -10M USD -145%
Income Tax Expense (Benefit) 4.23M USD -66.4%
Net Income (Loss) Attributable to Parent -33M USD +66.1%
Earnings Per Share, Basic -2 USD/shares +66%
Earnings Per Share, Diluted -2 USD/shares +65.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 58M USD -7.02%
Marketable Securities, Current 22.2M USD -21.8%
Accounts Receivable, after Allowance for Credit Loss, Current 22.2M USD -21.8%
Inventory, Net 16.3M USD -58.9%
Assets, Current 102M USD -25.4%
Deferred Income Tax Assets, Net 1.25M USD -15%
Property, Plant and Equipment, Net 40.7M USD -8.72%
Operating Lease, Right-of-Use Asset 24.2M USD -11%
Intangible Assets, Net (Excluding Goodwill) 1.65M USD -46.4%
Goodwill 8.05M USD +5.16%
Other Assets, Noncurrent 5.51M USD -51.3%
Assets 189M USD -18.1%
Accounts Payable, Current 4.73M USD -30.5%
Employee-related Liabilities, Current 8.11M USD -22.8%
Liabilities, Current 19.1M USD -25.1%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 22.8M USD -9.75%
Other Liabilities, Noncurrent 761K USD -5.58%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.94M USD +13.4%
Retained Earnings (Accumulated Deficit) 60.5M USD -35.3%
Stockholders' Equity Attributable to Parent 147M USD -18.4%
Liabilities and Equity 189M USD -18.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -130K USD -3.18%
Net Cash Provided by (Used in) Financing Activities -5.44M USD -139%
Net Cash Provided by (Used in) Investing Activities 1.67M USD
Common Stock, Shares Authorized 90M shares 0%
Common Stock, Shares, Issued 15.4M shares +1.78%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.79M USD +10.6%
Deferred Tax Assets, Valuation Allowance 45.1M USD +228%
Deferred Tax Assets, Gross 59.2M USD +97%
Operating Lease, Liability 25.9M USD
Depreciation 5.2M USD +7.69%
Payments to Acquire Property, Plant, and Equipment 2.82M USD +56.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -32.3M USD +66.6%
Property, Plant and Equipment, Gross 91.3M USD
Operating Lease, Liability, Current 1.73M USD -24.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.47M USD -21.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.78M USD -11.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) 18K USD -90.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.88M USD -13.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.33M USD -17.9%
Deferred Tax Assets, Operating Loss Carryforwards 650K USD -42.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1.25M shares 0%
Unrecognized Tax Benefits 600K USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.33M USD -11.9%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 600K USD -100%
Deferred Tax Assets, Net of Valuation Allowance 14.1M USD -13.8%
Share-based Payment Arrangement, Expense 11M USD -8.69%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%